Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s stock price traded up 1.6% on Wednesday . The company traded as high as $6.10 and last traded at $6.10. 200 shares traded hands during trading, a decline of 87% from the average session volume of 1,595 shares. The stock had previously closed at $6.00.
Silence Therapeutics Trading Up 1.6 %
The stock’s fifty day moving average is $6.18 and its two-hundred day moving average is $6.96.
Silence Therapeutics Company Profile
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
See Also
- Five stocks we like better than Silence Therapeutics
- Pros And Cons Of Monthly Dividend Stocks
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- How to Use the MarketBeat Dividend Calculator
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
